AOD-9604 + Tesamorelin + MOTS-c Blend
Purity: ≥97%
$95.00
≥98%HPLC Purity
COAIncluded
USAShipped
CJC-1295 (no DAC) + Ipamorelin Blend Peptide
Growth hormone secretagogue research blend combining CJC-1295 without DAC and Ipamorelin for synergistic GHRH/GHS-R pathway research.
$72.00
Quick Facts
| SKU | ACR-BL-CI |
|---|---|
| Sequence | CJC-1295 no DAC + Ipamorelin |
| Purity | ≥98% |
| Physical Form | Lyophilized Powder |
| Storage | Store at -20°C. |
About the CJC-1295 + Ipamorelin Research Blend
This blend combines CJC-1295 without DAC (Mod GRF 1-29, a GHRH receptor agonist) and Ipamorelin (a selective GHS-R1a/ghrelin receptor agonist). These two peptides target complementary receptor systems that converge on anterior pituitary somatotroph cells.
Published research has documented synergistic GH-releasing effects when GHRH pathway and ghrelin pathway are co-activated. CJC-1295 provides sustained GHRH receptor stimulation while Ipamorelin adds selective GHS-R1a activation without the cortisol/prolactin effects seen with less selective secretagogues.
For laboratory research use only.
Frequently Asked Questions
What is the CJC-1295 + Ipamorelin blend?
This blend combines CJC-1295 no DAC (GHRH receptor agonist) with Ipamorelin (selective ghrelin receptor agonist). They target complementary pathways on pituitary somatotrophs, producing synergistic GH release. For research use only.
For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.